FDA Notice Of Proposed Rulemaking On Hydroquinone Slated For June
This article was originally published in The Rose Sheet
Executive Summary
The Center for Drug Evaluation & Research's Division of OTC Drug Products plans to publish a notice of proposed rulemaking on hydroquinone, a cosmetic ingredient frequently used in skin brightening products, in June, FDA reported in its unified regulatory agenda, published in a Dec. 13 Federal Register 1notice